We've Moved
PharmAsia News has moved to a new enhanced Web platform. For continued news and analysis related to Asia, please visit our new site at www.pharmasianews.com and sign up for a 30-day free trial.
PharmAsia News has moved to a new enhanced Web platform. For continued news and analysis related to Asia, please visit our new site at www.pharmasianews.com and sign up for a 30-day free trial.
EDITOR’S PICK – Novartis has an Oct. 8 hearing before India’s Madras High Court to argue that the former head of the Indian Patent Office should be disqualified from considering the company’s appeal of a patent rejection for oncologic Gleevec (imatinib), according to The Economic Times of India.
EDITOR’S PICK – China’s Ministry of Health has sent a voluntary eight-page notice to the World Health Organization outlining steps the country has taken recently to improve food safety, according to an Aug. 29 report by the Associated Press.